The Manila Times56m agoLUNR Aerospace Corporation Obtains Receipt for Final Prospectus Accessible on SEDAR+TORONTO, Oct. 23, 2026 (GLOBE NEWSWIRE) -- LUNR Aerospace Corporation (the 'Corporation” or 'LUNR”) is pleased to announce that it has obtained a receipt for its final long form prospectus dated October 22, 2026 (the 'Prospectus”) from the Ontario Securities Commission qualifying the distribution of 7,925,925 common shares in the capital of the Corporation (the 'Common Shares”) issuable upon the automatic conversion of previously issued subscription receipts of the Corporation. Hampton Securitie56m ago
MarketScreener1h agoMaterials Down as Precious Metal Selloff Continues Materials RoundupProducers of metals, grains and other raw materials fell as the U.S. dollar neared multiyear highs ahead of the Federal Reserve's October meeting. Dollar-sensitive precious metals continued a...1h ago
MarketScreener2h agoConfused by Valuations? So Is the MarketStock markets fell sharply this week, weighed down by mixed corporate earnings, growing skepticism toward AI-related stocks and another surge in oil prices fueled by repeated attacks in the Persian... -October 23, 2026 at 05:07 pm EDT - MarketScreener2h ago
Seeking Alpha2h agoCerebras: I Waited For This Entry PointCerebras Systems Inc. stock is down 69%, but revenue, RPO, and cash are soaring. Click here to read this bullish analysis of the CBRS stock.2h ago
WTOP3h agoMetroCity: Q3 Earnings SnapshotDORAVILLE, Ga. (AP) — DORAVILLE, Ga. (AP) — MetroCity Bankshares, Inc. (MCBS) on Friday reported net income of $24.3 million in its third quarter. The Doraville3h ago
Times of India3h ago₹9,260 a quintal for cotton, but El Nino threatens yieldsCotton prices in Adilabad hit ₹9,260/quintal above MSP, but dry weather and El Niño fears may cut yields; CCI procurement delayed over moisture.3h ago
Free Press Journal4h agoTorrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr Reddy’s Laboratories reported a 36% profit decline to Rs 913.4 crore; revenue slipped 1.5% to Rs 8,671 crore and EBITDA fell 24.2% to Rs 1,783 crore, with its margin narrowing to 20.6%.4h ago
OilPrice5h agoSLB Earnings Beat Forecasts as Middle East Drilling ReboundsOilfield services giant SLB (NYSE: SLB) reported better-than-expected third-quarter earnings on Friday5h ago